title: Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCT.
authors.forename: S
authors.initials: S
authors.lastname: Shayani
authors.forename: J M
authors.initials: JM
authors.lastname: Palmer
authors.forename: T
authors.initials: T
authors.lastname: Stiller
authors.forename: H
authors.initials: H
authors.lastname: Chan
authors.forename: S
authors.initials: S
authors.lastname: Keuylian
authors.forename: P
authors.initials: P
authors.lastname: Parker
authors.forename: S
authors.initials: S
authors.lastname: Thomas
authors.forename: V
authors.initials: V
authors.lastname: Pullarkat
authors.forename: A
authors.initials: A
authors.lastname: Nademanee
authors.forename: S J
authors.initials: SJ
authors.lastname: Forman
authors.forename: R
authors.initials: R
authors.lastname: Nakamura
mesh_terms: D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000494:pharmacology*; D000077608:Aprepitant; D004347:Drug Interactions; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000494:pharmacology*; D012189:Retrospective Studies; D020123:Sirolimus / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D016559:Tacrolimus / Q000008:administration & dosage / Q000097:blood; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D000932:Antiemetics; D007166:Immunosuppressive Agents; D009025:Morpholines; D000077608:Aprepitant; D020123:Sirolimus; D016559:Tacrolimus